In the global medical devices industry, there were 168 M&A deals announced in Q3 2024, worth a total value of $14.4bn, according to GlobalData’s Deals Database. The $3.8bn acquisition of Baxter International by Carlyle Group was the industry’s largest disclosed deal. GlobalData’s Medical Devices Industry Mergers and Acquisitions Deals by Top Themes in Q3 2024 report helps understand the pivotal themes steering M&A activity in the industry. Buy the report here.

Smarter leaders trust GlobalData

In value terms, M&A activity decreased by 32% in Q3 2024 compared with the previous quarter’s total of $21.2bn and rose by 247% as compared to Q3 2023. Related deal volume increased by 30% in Q3 2024 versus the previous quarter and was 47% higher than in Q3 2023.

Notably, foreign direct investments (fdi)-related deals accounted for a 39% share of the global medical devices industry’s M&A activity in Q3 2024, up 33% over the previous quarter.

The top-ranked financial advisors supporting these M&A deals in 9M 2024 were Jefferies Financial Group; Evercore; Stifel Financial with 6, 4, 4 deals respectively.

The top-ranked legal advisors supporting these M&A deals in 9M 2024 were Kirkland & Ellis; CMS Legal Services EEIG; Weil, Gotshal & Manges with 14, 8, 6 deals respectively.

For further understanding of GlobalData's Medical Devices Industry Mergers And Acquisitions Deals By Top Themes In Q3 2024 – Strategic Intelligence, buy the report here.

This content was updated on 19 October 2024

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Deals Database tracks global deal activity, including mergers, acquisitions, capital raising, strategic alliances, and licensing agreements. Proprietary analysis is used to group deals into key thematic areas and granular sectors across the world’s largest industries.

This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Deal type includes Acquisition, Asset transactions and Mergers.